logo

Quick Facts

Share SHARE

AbbVie (ABBV), a research-based biopharmaceutical company, and Biogen (BIIB) late Friday announced that the U.S. Food and Drug Administration or FDA approved ZINBRYTA (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis or RMS. Biogen...

O'Reilly Automotive, Inc. (ORLY), a retailer in the automotive aftermarket industry, announced Friday that its Board of Directors approved a resolution to increase the authorization amount under its share repurchase program by an additional $750 million, raising the aggregate authorization under the...

Lincoln Financial Group (LNC) announced that the board of directors of Lincoln National Corporation declared a quarterly cash dividend of $0.25 per share on the corporation's common stock. The dividend on the common stock will be payable August 1, 2016 to shareholders of record at the close of business...

A. M. Castle & Co. (CAS), a global distributor of specialty metal and supply chain solutions, announced that it has reached an agreement with Raging Capital Management, LLC on the composition of the Company's Board of Directors and matters relating to the 2016 annual meeting of shareholders. As per...

Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transaction, with approximately 98.9 percent of shares outstanding cast in favor of the proposal. Earlier, Shire shareholders of approximately...

Nexstar Broadcasting Group, Inc. (NXST) said it has entered into three definitive agreements to divest five television stations in four markets. The proposed divestitures mark an important first step in fulfilling Nexstar's commitment to regulatory bodies to consummate its previously announced agreement...

Terex Corp. (TEX) announced discussions with Zoomlion Heavy Industry Science and Technology Co. regarding the purchase of Terex, either with or without the MHPS segment, have been terminated. TEX is closed Thursday's regular trading at $24.33, down $0.87 or 3.45 percent. In the Friday Pre-Market trade,...

Johnson Controls (JCI) and Tyco International (TYC) announced the senior executive team that will lead the combined company following the close of their planned merger, which is expected on or around October 1, 2016. As previously announced, at the effective time of the merger, Johnson Controls chairman...

Merck & Co. Inc. (MRK) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending approval of ZEPATIER (elbasvir and grazoprevir), an investigational, once-daily, fixed-dose combination tablet for the treatment...

Gilead Sciences Inc. (GILD) announced that the Committee for Medicinal Products for Human Use or CHMP, the scientific committee of the European Medicines Agency or EMA, has adopted a positive opinion on the company's Marketing Authorization Application or MAA for Epclusa, an investigational, pan-genotypic,...

Amgen (AMGN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion to extend the current indication for Kyprolis or carfilzomib to include treatment in combination with dexamethasone alone for adult patients with multiple...

AstraZeneca (AZN.L, AZN) announced positive results from the Phase III FALCON trial comparing fulvestrant 500mg to anastrozole 1mg for the treatment of locally-advanced or metastatic breast cancer, in postmenopausal women who have not had prior hormonal treatment for hormone receptor positive or HR+...

Thermo Fisher Scientific Inc. (TMO) said that it agreed to buy FEI Company (FEIC) for $107.50 per share in cash. The transaction represents a purchase price of approximately $4.2 billion. FEI designs, manufactures and supports high-performance electron microscopy workflows that provide images and...

Big Lots, Inc. (BIG) announced that it expects second-quarter adjusted income from continuing operations to be in the range of $0.42 to $0.47 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $0.45 per share for the second quarter. Analysts' estimates typically exclude...

Cameco Corp. (CCO.TO, CCJ) signed an agreement with Joint Stock Company National Atomic Company Kazatomprom and Joint Venture Inkai LLP to restructure and enhance JV Inkai. The new agreement replaces the memorandum of agreement signed by Cameco and Kazatomprom in September 2012. Cameco's ownership interest...

Follow RTT